Axon Therapies Overview

  • Founded
  • 2014

Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $8M

  • Investors
  • 3

Axon Therapies General Information

Description

Developer of a healthcare device and procedure designed to reduce sympathetic nerve activity and address the root cause of heart failure. The company's device allows clinicians to ablate the right greater splanchnic nerve using a small catheter inserted through the groin and helps to normalize sympathetic nervous activity, with the intention to shift blood volume from the heart back to the splanchnic bed, reducing pressures in the heart, enabling clinicians to begin treatment more quickly, resulting in a higher likelihood of successful treatment.

Contact Information

Website
www.axontherapies.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • 2326 Walsh Avenue
  • Santa Clara, CA 95051
  • United States
+1 (408) 000-0000

Axon Therapies Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axon Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - General 25-Apr-2023 $8M 000.00 Completed Clinical Trials - General
5. Later Stage VC (Series A) 28-Jan-2021 0000 000.00 000.00 Completed Clinical Trials - General
4. Later Stage VC (Series A) 07-Feb-2019 00.00 000.00 000.00 Completed Clinical Trials - General
3. Early Stage VC (Series AA) 26-Jun-2017 00.00 00.00 00.00 Completed Clinical Trials - General
2. Early Stage VC (Series AA) 19-Apr-2016 $2M $2M 00.00 Completed Clinical Trials - General
1. Accelerator/Incubator Completed Startup
To view Axon Therapies’s complete valuation and funding history, request access »

Axon Therapies Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A V 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series AA NV 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00
Series AA V 1,650,000 $0.001000 $0.12 $2 $2 1x $2 6.09%
Series A NV 21,986,785 $0.001000 $0.12 $1.48 $1.48 1x $1.24 0%
To view Axon Therapies’s complete cap table history, request access »

Axon Therapies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare device and procedure designed to reduce sympathetic nerve activity and address the root cause
Surgical Devices
Santa Clara, CA
18 As of 2023
000.00
000000000 000.00

000000

aboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehe
00000000 0000000
Irvine, CA
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

000000

s aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fug
00000 0000000 000 00
Seattle, WA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axon Therapies Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ClearFlow Venture Capital-Backed Irvine, CA 00 0000 00000000000 0000
00000000 0000000 0 Venture Capital-Backed Seattle, WA 000 00000 00000000000 00000
000000 0000 000000 Venture Capital-Backed Santa Rosa, CA 00 00000 000000 - 000 00000
0000000000 Venture Capital-Backed San Ramon, CA 00 00000 00000000000 00000
00000 00000000000 Formerly VC-backed Bellevue, WA 000 000.00 000000&0 000.00
You’re viewing 5 of 25 competitors. Get the full list »

Axon Therapies Patents

  • 54

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 7

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Axon Therapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220323142-A1 Methods, systems and devices for endovascular electroporation of a greater splanchnic nerve Pending 23-Dec-2020 00000000000
CA-3162954-A1 Methods and devices for endovascular ablation of a splanchnic nerve Pending 17-Jan-2020
AU-2021208701-A1 Methods and devices for endovascular ablation of a splanchnic nerve Pending 17-Jan-2020 00000000000
EP-4209191-A1 Catheter and computer for calculation of accumulated volume of liquid delivered into a patient Pending 17-Jan-2020 00000000000 00
EP-3902494-A4 Methods and devices for endovascular ablation of a splanchnic nerve Active 17-Jan-2020 A61B18/1492 0
To view Axon Therapies’s complete patent history, request access »

Axon Therapies Executive Team (4)

Name Title Board Seat Contact Info
Chad Hoskins Chief Executive Officer, President & Board Member
Zoar Engelman Co-Founder & Chief Science Officer
Mark Gelfand Co-Founder, Chief Technology Officer & Board Member
Howard Levin MD Co-Founder, Senior Clinical Advisor & Board Member
To view Axon Therapies’s complete executive team members history, request access »

Axon Therapies Board Members (8)

Name Representing Role Since
Andrew ElBardissi MD Deerfield Management Board Member 000 0000
Brian Farley Self Board Member 000 0000
David Neustaedter Ph.D Self Board Member 000 0000
Howard Levin MD Self Co-Founder, Senior Clinical Advisor & Board Member 000 0000
Imran Eba Action Potential Venture Capital Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Axon Therapies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axon Therapies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Deerfield Management Venture Capital Minority 000 0000 000000 0
Action Potential Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
Coridea VC-Backed Company 000 0000 000000 0
To view Axon Therapies’s complete investors history, request access »

Ready to get started?

Request a free trial